1. Home
  2. LRMR vs FRGE Comparison

LRMR vs FRGE Comparison

Compare LRMR & FRGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LRMR
  • FRGE
  • Stock Information
  • Founded
  • LRMR N/A
  • FRGE 2014
  • Country
  • LRMR United States
  • FRGE United States
  • Employees
  • LRMR N/A
  • FRGE N/A
  • Industry
  • LRMR Biotechnology: Pharmaceutical Preparations
  • FRGE Computer Software: Prepackaged Software
  • Sector
  • LRMR Health Care
  • FRGE Technology
  • Exchange
  • LRMR Nasdaq
  • FRGE Nasdaq
  • Market Cap
  • LRMR 183.8M
  • FRGE 159.4M
  • IPO Year
  • LRMR N/A
  • FRGE N/A
  • Fundamental
  • Price
  • LRMR $2.12
  • FRGE $14.55
  • Analyst Decision
  • LRMR Strong Buy
  • FRGE Buy
  • Analyst Count
  • LRMR 9
  • FRGE 3
  • Target Price
  • LRMR $19.00
  • FRGE $52.50
  • AVG Volume (30 Days)
  • LRMR 1.4M
  • FRGE 251.1K
  • Earning Date
  • LRMR 04-30-2025
  • FRGE 05-07-2025
  • Dividend Yield
  • LRMR N/A
  • FRGE N/A
  • EPS Growth
  • LRMR N/A
  • FRGE N/A
  • EPS
  • LRMR N/A
  • FRGE N/A
  • Revenue
  • LRMR N/A
  • FRGE $85,383,000.00
  • Revenue This Year
  • LRMR N/A
  • FRGE $20.86
  • Revenue Next Year
  • LRMR N/A
  • FRGE $28.07
  • P/E Ratio
  • LRMR N/A
  • FRGE N/A
  • Revenue Growth
  • LRMR N/A
  • FRGE 16.04
  • 52 Week Low
  • LRMR $1.61
  • FRGE $6.60
  • 52 Week High
  • LRMR $11.20
  • FRGE $29.85
  • Technical
  • Relative Strength Index (RSI)
  • LRMR 44.72
  • FRGE 61.45
  • Support Level
  • LRMR $2.03
  • FRGE $11.88
  • Resistance Level
  • LRMR $2.33
  • FRGE $14.53
  • Average True Range (ATR)
  • LRMR 0.30
  • FRGE 1.29
  • MACD
  • LRMR -0.01
  • FRGE 0.09
  • Stochastic Oscillator
  • LRMR 11.21
  • FRGE 85.46

About LRMR Larimar Therapeutics Inc.

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using novel cell-penetrating peptide technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.

About FRGE Forge Global Holdings Inc.

Forge Global Holdings Inc is a financial service platform created to serve the needs of the private market. It provides marketplace infrastructure, data services, and technology solutions for private market participants. The company offers a trusted trading platform, proprietary data and insights to inform investment strategies, along with custody services to help companies, shareholders, institutions and accredited investors confidently navigate and transact in the private market.

Share on Social Networks: